U.S. Markets closed
S&P Futures
4,403.75-11.25(-0.25%)Dow Futures
34,741.00-257.00(-0.73%)Nasdaq Futures
15,089.50+43.25(+0.29%)Russell 2000 Futures
2,196.90-22.50(-1.01%)Crude Oil
68.47-2.09(-2.96%)Gold
1,813.60-0.50(-0.03%)
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
228.31-15.77 (-6.46%)
At close: 4:00PM EDT
228.00 -0.31 (-0.14%)
After hours: 07:56PM EDT
After hours: 07:56PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 244.08 |
| Open | 238.37 |
| Bid | 228.92 x 800 |
| Ask | 229.07 x 900 |
| Day's Range | 227.10 - 239.42 |
| 52 Week Range | 210.28 - 276.69 |
| Volume | 6,931,087 |
| Avg. Volume | 2,425,562 |
| Market Cap | 131.176B |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | 18.91 |
| EPS (TTM) | 12.07 |
| Earnings Date | Oct 26, 2021 - Nov 01, 2021 |
| Forward Dividend & Yield | 7.04 (2.95%) |
| Ex-Dividend Date | May 14, 2021 |
| 1y Target Est | 254.96 |
- Investor's Business Daily
Amgen Stock Dips On Guidance Trim Despite Second-Quarter Beat
Amgen stock dipped late Tuesday after reporting adjusted income of $4.38 per share on $6.53 billion in second-quarter sales.
- Motley Fool
Why Amgen Is Down Nearly 7% Today
The biopharma name cautioned shareholders that it's still suffering from a pandemic hangover, but investors should think bigger-picture.
- Benzinga
Amgen Stops Phase 1 For One BiTE Molecule While Resuming Dosing For Another, Plans Second Drug Substance Plant
View more earnings on AMGNSee more from BenzingaClick here for options trades from BenzingaAmgen Q2 Profit Falls On Five Prime Acquisition Related Write-off, Disputes IRS Claim On Owing .6B In TaxesAmgen Buys Antibody Player Focused On PSMA In .5B Deal© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
© 2021 Verizon Media. All rights reserved.
